Institute of Molecular Biology and Biotechnology
The Institute of Molecular Biology and Biotechnology (IMBB) at the Faculty of Biology of Adam Mickiewicz University in Poznań, Poland was created in 1992. The Institute’s mission is to perform outstanding research to reveal functions of the cell and organism at the molecular level. Organisms belonging to all domains of life are studied in IMBB: bacteria, animals, fungi, and plants.
Studies encompass basic research on gene expression regulation, epigenetics and other aspects of chromatin structure, microRNA, alternative splicing, molecular mechanisms of translation regulation, molecular basis of energy conversion as well as understanding of renal disease, viral infection, atherosclerosis and myotonic dystrophy at both the molecular and clinical levels. In addition, the IMBB scientists are also involved in translational science developing assays for diagnostic and prognostic applications in various human diseases, identifying and characterizing novel therapeutic targets, searching for small molecule inhibitors of RNA-protein interactions that can be used as drugs, and developing therapies involving antisense oligomers to threat myotonic dystrophy. In IMBB the molecular basis of plant response to various environmental cues is also intensively studied. This part of IMBB research is strongly connected with agrobiotechnological tasks to obtain crop plants that are more adaptable to changing climate conditions. Bioinformatics is recognized as a fundamental component of modern biology. For the past several years, IMBB has invested numerous resources for the development of this dynamic field. Computational biology at IMBB is focused on genome analysis and gene discovery, comparative and evolutionary genomics, and on general mechanisms of evolution. Moreover, studies on the relationship between the sequence, structure and function of proteins and RNAs, as well as the modelling of RNA-protein structures, are also conducted. An important goal of in silico studies performed at IMBB is the discovery of new drugs that is carried out in close collaboration with molecular biologists and clinicians. One of the most important activities of IMBB bioinformaticians is the development of advanced algorithms to support biotechnological research. A strong connection between computational analyses and bench experiments is a trademark of IMBB.
Scientific cooperation is stimulated and supported by international research projects within the limits of bilateral agreements and programs of the European Union and the organization of the international workshops and conferences.
Our PhD program is designed to prepare young scientists for successful careers in research, teaching, and industry throughout the world. If you are interested in applying please contact directly any of the IMBB group leaders or contact the IMBB secretariat: